CURV
Q3 2026 EPS Estimate
$-0.03
Sep 3, 2026 · Reports after close
Revenue Estimate
$237M
FY2028E EPS$0.04
FY2029E EPS$0.04

Analyst Sentiment

Wall St. Consensus
Hold
10 analysts·Moderate coverage
48
Score
1 Buy (10%)7 Hold (70%)2 Sell (20%)
Rating Breakdown
Strong Buy
00%
Buy
110%
Hold
770%
Sell
220%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$1.80
-17.6%
Consensus
$1.80
-17.6%
Bull
$1.80
-17.6%
12-Month Target Range10 analysts
$1.80$1.80$1.80
Current $2.19Consensus
Current Price
$2.19
Above Consensus
$0.39

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev-4.33%
EPS
FY2028
Rev+1.80%
EPS
FY2029
Rev+0.27%
EPS-0.89%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027EFY2028EFY2029E
Revenue Avg$952M$969M$972M
Low$950M$955M$953M
High$954M$978M$991M
EBITDA Avg$101M$103M$103M
Low$101M$101M$101M
High$101M$104M$105M
EBIT Avg$45M$46M$46M
Low$45M$45M$45M
High$45M$47M$47M
Net Income Avg$-3M$4M$4M
Low$-5M$-941,965$4M
High$772,886$8M$4M
EPS Avg$-0.02$0.04$0.04
Low$-0.05$-0.01$0.04
High$0.01$0.08$0.04
Analysts (Rev / EPS)5 / 45 / 52 / 1
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028
Revenue Avg$227M$242M$249M$242M$231M$244M$282M$287M
Low$226M$239M$247M$240M$229M$242M$279M$284M
High$228M$244M$251M$244M$233M$246M$284M$289M
EBITDA Avg$24M$26M$26M$26M$25M$26M$30M$30M
Low$24M$25M$26M$25M$24M$26M$30M$30M
High$24M$26M$27M$26M$25M$26M$30M$31M
EBIT Avg$11M$12M$12M$12M$11M$12M$13M$14M
Low$11M$11M$12M$11M$11M$12M$13M$14M
High$11M$12M$12M$12M$11M$12M$14M$14M
Net Income Avg$986,899$-910,149$3M$-980,528$3M$515,150$4M$286,692
Low$-986,899$-919,167$3M$-990,243$3M$508,417$4M$282,945
High$2M$-898,252$3M$-967,711$3M$520,255$4M$289,533
EPS Avg$0.01$-0.01$0.03$-0.01$0.03$0.01$0.04$0.00
Low$-0.01$-0.01$0.03$-0.01$0.03$0.01$0.04$0.00
High$0.02$-0.01$0.03$-0.01$0.03$0.01$0.04$0.00
Analysts (Rev / EPS)4 / 42 / 12 / 12 / 12 / 11 / 21 / 21 / 2

Earnings Surprises

Recent Analyst Actions

Jul 6, 2026Morgan Stanley
Torrid resumed with an Equal Weight at Morgan Stanley
Target:$1.80
+2.9%from $1.75
Dec 4, 2025Morgan Stanley
Torrid Holdings Inc (CURV) PT Lowered to $1.01 at Morgan Stanley
Target:$1.01
-10.6%from $1.13
Dec 4, 2025Telsey Advisory
Torrid price target lowered to $2 from $3 at Telsey Advisory
Target:$2.00
+76.2%from $1.14
Sep 18, 2025Morgan Stanley
Torrid price target lowered to $1.60 from $2 at Morgan Stanley
Target:$1.60
-12.8%from $1.83
Apr 1, 2024Telsey Advisory
Torrid price target raised to $6 from $5 at Telsey Advisory
Target:$6.00
+12.1%from $5.35
Mar 29, 2024Jefferies
Torrid Holdings Inc (CURV) PT Raised to $4.80 at Jefferies
Target:$4.80
-1.6%from $4.88
May 19, 2023Telsey Advisory
Torrid Weathering Leadership Transitions, Still Well-Positioned Among Industry Peers, Analyst Says
Target:$5.00
+82.1%from $2.75
Dec 12, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Torrid Holdings, Lowers Price Target to $3.5
Target:$3.50
+9.9%from $3.19
Dec 9, 2022Telsey Advisory
Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $6
Target:$6.00
+40.5%from $4.27
Sep 22, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Torrid Holdings, Lowers Price Target to $5
Target:$5.00
+4.0%from $4.81
Sep 8, 2022Telsey Advisory
Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $7
Target:$7.00
+30.4%from $5.37
Aug 4, 2022Telsey Advisory
Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $8
Target:$8.00
+83.9%from $4.35
Jun 8, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Torrid Holdings, Lowers Price Target to $7
Target:$7.00
+21.1%from $5.78
Jun 8, 2022Telsey Advisory
Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $12
Target:$12.00
+106.5%from $5.81
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.